Premier Biotech Acquires National Test Systems
November 5, 2025
Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.
- Buyers
- Premier Biotech, Align Capital Partners
- Targets
- National Test Systems
- Platforms
- Premier Biotech
- Industry
- Medical Devices
- Location
- Florida, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Premier Biotech Acquires NexScreen and TransMed
June 19, 2026
Healthcare Services
Premier Biotech (backed by Align Capital Partners) announced the acquisitions of NexScreen and TransMed to expand its drug and alcohol testing diagnostic product portfolio and global footprint. The deals add NexScreen’s point-of-care diagnostic testing presence in Australia and New Zealand and TransMed’s drug testing product catalog, e-commerce platform, and direct customer base.
-
Premier Biotech Acquires NexScreen and TransMed
June 18, 2026
Healthcare Services
Align Capital Partners-backed Premier Biotech announced the acquisitions of NexScreen and TransMed to expand its product portfolio, e-commerce capabilities, and global footprint. NexScreen adds point-of-care diagnostic testing presence in Australia and New Zealand, while TransMed strengthens Premier’s catalog and online distribution to 1,000+ direct customer accounts.
-
Premier Biotech Acquires GH Solutions to Expand Point-of-Care Testing Presence
April 9, 2026
Healthcare Services
Align Capital Partners-backed Premier Biotech has acquired GH Solutions, a distributor of point-of-care diagnostic testing products. The deal expands Premier’s customer base and broadens the solutions GH can offer to Premier’s existing network, with focus on government and workplace customers.
-
Premier Biotech Acquires Desert Tox
June 6, 2024
Healthcare Services
Premier Biotech, a toxicology testing provider backed by Align Capital Partners, has acquired Desert Tox, LLC, a SAMHSA‑certified laboratory that provides urine and oral fluid testing across HHS/DOT, employment, occupational health and government markets. The founders, Mike Grommes and Mike Gorman, will remain involved; the deal is Premier's first add-on since ACP's acquisition in November 2022 and expands Premier's national service offering and oral fluids capabilities.
-
Align Capital Partners Recapitalizes Premier Biotech
December 7, 2022
Medical Devices
Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.
-
Element Materials Technology Acquires National Technical Systems (NTS)
September 27, 2022
Industrial Services
Element Materials Technology has completed the acquisition of National Technical Systems (NTS) from Aurora Capital Partners. The deal expands Element's North American footprint and testing, inspection and certification capabilities across aerospace, defense, automotive, medical and connected-technology end markets.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.